Back to News
investment

4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow

Seeking Alpha
Loading...
1 min read
1 views
0 likes
4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow

Summarize this article with:

SA Transcripts157.39K FollowersFollow5ShareSaveCommentsThe following slide deck was published by 4D Molecular Therapeutics, Inc. in conjunction with this event. This article was written bySA Transcripts157.39K FollowersFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Read Original

Source Information

Source: Seeking Alpha